fda cder regulatory science: improving drug review with data standards
Published 6 years ago • 3.8K plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
3:41
fda cder regulatory science: patient-focused drug development
-
1:00
data standards: improving drug review
-
3:32
about fda’s data standards program
-
3:56
fda cder regulatory science: real world evidence
-
3:44
fda cder regulatory science: the importance of partnership and consortia
-
56:35
send for cber, what you need to know
-
54:21
most common issues with cdisc-send data in fda toxicology review – sep. 12, 2019
-
1:26:29
digital health technologies (dhts) for remote data acquisition draft guidance
-
1:19:19
generic drugs forum (gdf) 2024: regulatory considerations to enhance generic drug access-day 2, pt 3
-
57:58
common cmc (quality) issues and how to avoid them part i (12of16) generic drugs forum
-
0:15
what is fda’s role in regulating drugs? (15 seconds)
-
43:14
introduction to regulatory science at the fda
-
5:06
what is regulatory science? (video-full version)
-
55:12
ich q12 guidance and emerging technology program (11of16) generic drugs forum 2020
-
54:27
fda's sentinel initiative - pharmacovigilance 2020
-
36:06
what can cder do for you? (3of15) redi annual conference – may 29-30, 2019
-
25:59
fda’s inactive ingredient database (iid) (3of35) complex generics – sep. 25-26, 2019
-
37:46
clinical pharmacology regulatory sciences in drug development and precision medicine
-
35:52
pre-anda interactions with the fda (6of16) generic drugs forum 2020
-
56:38
2021 fda science forum: main session and keynote
-
40:19
cder’s review of the prescribing information (11of15) redi– may 29-30, 2019
-
1:11
about fda’s regulatory science program